1. 4CPS-121 Emergency medicine clinical pharmacist's interventions and their impact on preventable adverse drug events. (23rd March 2022) Authors: Garreta, G; Sebastian, C; Iglesias, M; Salazar, F; Meca, N; Pardo, J; Sangrador, C; Nicolas, J Journal: European journal of hospital pharmacy Issue: Volume 29(2022)Supplement 1 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4CPS-122 Overview of the impact of penicillin allergy labels on antibiotic use in the emergency department. (23rd March 2022) Authors: Garreta, G; Meca, N; Sebastian, C; Iglesias, M; Salazar, F; Pardo, J; Nicolas, J Journal: European journal of hospital pharmacy Issue: Volume 29(2022)Supplement 1 Page Start: A71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4CPS-233 Therapeutic switch of antiretroviral treatments: efficacy, tolerability and reason for change. (23rd March 2022) Authors: Meca, N; Pardo, J; Garreta, G; Sebastián, C; Iglesias, M; Salazar, F; Nicolás, J Journal: European journal of hospital pharmacy Issue: Volume 29(2022)Supplement 1 Page Start: A107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 5PSQ-036 Polypharmacy and deprescribing in HIV-infected elderly population. (March 2019) Authors: Gallardo, S; Pardo, J; March, P; Garreta, G; Sangrador, C; Nicolás, J Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Catecholamine levels in plasma and CSF in migraine. Issue 10 (October 1993) Authors: Martínez, F; Castillo, J; Pardo, J; Lema, M; Noya, M Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 56:Issue 10(1993) Page Start: 1119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P05.81 Neurocognitive assessment in cancer patients without central nervous system disease treated with bevacizumab at week 34: an observational transversal multi-centric pilot study. (19th September 2018) Authors: Panciroli, C; Lucente, G; Cecilia, O; Quiroga, V; Carcereny, E; Pardo, J; Romeo, M; Velarde, J; Villa, S; Balaña, C Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗